ABIONYX Pharma: Combined General Meeting in Camera on June 11, 2021 : Remote Participation Modalities and Office Composition
01 Giugno 2021 - 8:13PM
Business Wire
Regulatory News:
ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible),
a new generation biotech company dedicated to the discovery and
development of innovative therapies for patients.
In the context of the Covid-19 pandemic and in order to protect
all shareholders, the Board of Directors has decided to hold the
Combined General Meeting of June 11, 2021 at 9:00 am at the
headquarters, in camera, without the physical presence of the
shareholders and other persons entitled to attend.
On June 1st, 2021, the Chief Executive Officer, upon delegation
of the Board of Directors, proceeded, in accordance with the
provisions of article 8 of the extended and modified decree n°
2020-418 of April 10, 2020, to appoint Mr. Luc Demarre and Mr.
Cyrille Tupin as scrutineers for the next Combined General Meeting
of Shareholders of ABIONYX PHARMA. In accordance with the
regulations, they are among the ten shareholders with the highest
number of voting rights of which the company is aware at the date
of convening the meeting.
The Shareholders’ Meeting will be webcasted (in French) at :
https://us02web.zoom.us/webinar/register/WN_ZBl-hvI-RticThbW6Wjkiw
The shareholders’ presentation will be released on the company’s
web site at 8:45 am (CEST) on the day of the meeting.
About ABIONYX Pharma ABIONYX Pharma is a new generation
biotech company dedicated to the discovery and development of
innovative therapies for patients. The biotech assets inherited
from CERENIS Therapeutics constitute a rich portfolio of valuable
programs for the treatment of metabolic diseases as well as with a
HDL targeted drug delivery platform.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210601005940/en/
NewCap Investor relations Louis-Victor Delouvrier
abionyx@newcap.eu +33 (0)1 44 71 98 53
NewCap Media relations Nicolas Merigeau abionyx@newcap.eu
+33 (0)1 44 71 94 98
Grafico Azioni Abionyx Pharma (EU:ABNX)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Abionyx Pharma (EU:ABNX)
Storico
Da Apr 2023 a Apr 2024